JP2010539107A5 - - Google Patents

Download PDF

Info

Publication number
JP2010539107A5
JP2010539107A5 JP2010524335A JP2010524335A JP2010539107A5 JP 2010539107 A5 JP2010539107 A5 JP 2010539107A5 JP 2010524335 A JP2010524335 A JP 2010524335A JP 2010524335 A JP2010524335 A JP 2010524335A JP 2010539107 A5 JP2010539107 A5 JP 2010539107A5
Authority
JP
Japan
Prior art keywords
solution
composition
neuregulin
organ
storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010524335A
Other languages
English (en)
Japanese (ja)
Other versions
JP5421916B2 (ja
JP2010539107A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2008/001610 external-priority patent/WO2009033373A1/en
Publication of JP2010539107A publication Critical patent/JP2010539107A/ja
Publication of JP2010539107A5 publication Critical patent/JP2010539107A5/ja
Application granted granted Critical
Publication of JP5421916B2 publication Critical patent/JP5421916B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010524335A 2007-09-12 2008-09-12 臓器保存のためのニューレグリンの使用 Active JP5421916B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99356607P 2007-09-12 2007-09-12
US60/993,566 2007-09-12
PCT/CN2008/001610 WO2009033373A1 (en) 2007-09-12 2008-09-12 Use of neuregulin for organ preservation

Publications (3)

Publication Number Publication Date
JP2010539107A JP2010539107A (ja) 2010-12-16
JP2010539107A5 true JP2010539107A5 (https=) 2011-11-04
JP5421916B2 JP5421916B2 (ja) 2014-02-19

Family

ID=40451568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010524335A Active JP5421916B2 (ja) 2007-09-12 2008-09-12 臓器保存のためのニューレグリンの使用

Country Status (5)

Country Link
US (2) US20090156488A1 (https=)
EP (2) EP2586305A1 (https=)
JP (1) JP5421916B2 (https=)
CN (1) CN101877961B (https=)
WO (1) WO2009033373A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP785098A0 (en) * 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
WO2003099320A1 (en) * 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
JP5738516B2 (ja) 2005-12-30 2015-06-24 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド 心機能改善のためのニューレグリンの徐放
JP5743898B2 (ja) * 2008-11-28 2015-07-01 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド ニューレグリンペプチド及びその使用
EP3087998B1 (en) * 2009-06-09 2019-09-04 Zensun (Shanghai) Science & Technology, Co., Ltd. Neuregulin based methods for treating heart failure
CN102470161A (zh) 2009-06-09 2012-05-23 上海泽生科技开发有限公司 神经调节蛋白用于治疗心力衰竭的有效剂量
WO2011011388A2 (en) * 2009-07-22 2011-01-27 Children's Medical Center Corporation Neuregulin induced regeneraton of heart muscle muscle
JP6096262B2 (ja) 2009-08-25 2017-03-15 ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． ニューレグリンに基づく心不全の治療方法
CN102139095A (zh) * 2010-01-29 2011-08-03 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
CN104399062A (zh) * 2011-01-11 2015-03-11 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
WO2013053076A1 (en) * 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
US10894815B2 (en) 2012-10-08 2021-01-19 Zensun (Shanghai) Science & Technology, Co., Ltd. Compositions and methods for treating heart failure in diabetic patients
RU2015154737A (ru) 2013-05-22 2017-06-27 Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи, Ко., Лтд. Пролонгированное высвобождение нейрегулина для лечения сердечной недостаточности
CN104758922A (zh) * 2014-01-03 2015-07-08 上海泽生科技开发有限公司 纽兰格林制剂的配方
CN105497876B (zh) 2014-09-24 2021-01-15 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物
CN105561298A (zh) 2014-10-17 2016-05-11 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
AR121035A1 (es) 2019-04-01 2022-04-13 Lilly Co Eli Compuestos de neuregulina-4 y métodos de uso
TW202306975A (zh) 2021-06-10 2023-02-16 美商安進公司 對ｅｒｂｂ４而非ｅｒｂｂ３具有改善的選擇性的工程化ｎｒｇ－１變體

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
EP0052322B1 (de) 1980-11-10 1985-03-27 Gersonde, Klaus, Prof. Dr. Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4640835A (en) * 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
JPS58118008A (ja) 1982-01-06 1983-07-13 Nec Corp デ−タ処理装置
DE3374837D1 (en) 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3483949D1 (de) 1983-09-26 1991-02-21 Udo Dr Med Ehrenfeld Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
EP0143949B1 (en) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
DE3675588D1 (de) * 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4798824A (en) * 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) * 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5834229A (en) * 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US7037888B1 (en) * 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
FI943071L (fi) 1993-06-24 1994-12-25 Takeda Chemical Industries Ltd Anti-endoteliiniainetta pysyvästi vapauttava valmiste
US5912326A (en) 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
CA2270423C (en) * 1996-10-31 2009-09-15 Mochida Pharmaceutical Co., Ltd. Prophylactic/therapeutic agent
US6054261A (en) * 1998-05-20 2000-04-25 Q-Pharma, Inc. Coenzyme Q10 compositions for organ protection during perfusion
US6045990A (en) * 1998-07-09 2000-04-04 Baust; John M. Inclusion of apoptotic regulators in solutions for cell storage at low temperature
AUPP785098A0 (en) * 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
EP1305040B1 (en) * 2000-07-28 2009-09-09 Christopher J. Murphy Transplant media
EP2400021B1 (en) * 2002-03-26 2016-11-30 Zensun (Shanghai) Science & Technology, Co., Ltd. ErbB3 based methods and compositions for treating neoplasms
WO2003099320A1 (en) * 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
AU2003237367A1 (en) * 2002-06-03 2003-12-19 Chiron Corporation Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
AU2003300435A1 (en) * 2002-12-31 2004-07-29 The Board Of Trustees Of The University Of Illinois Tissue and organ preservation, protection and resuscitation
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs
US20070141548A1 (en) * 2005-03-11 2007-06-21 Jorg Kohl Organ transplant solutions and method for transplanting organs
WO2006128125A2 (en) * 2005-05-27 2006-11-30 Five Prime Therapeutics, Inc. Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
US20070213264A1 (en) * 2005-12-02 2007-09-13 Mingdong Zhou Neuregulin variants and methods of screening and using thereof
US20070148628A1 (en) * 2005-12-09 2007-06-28 Philadelphia College Of Osteopathic Medicine Organ preservation and/or perfusion
JP5738516B2 (ja) * 2005-12-30 2015-06-24 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド 心機能改善のためのニューレグリンの徐放
US9580515B2 (en) * 2006-08-21 2017-02-28 Zensun (Shanghai) Science & Technology, Co., Ltd. Neukinase, a downstream protein of neuregulin
JP5743898B2 (ja) * 2008-11-28 2015-07-01 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド ニューレグリンペプチド及びその使用
JP2012509908A (ja) * 2008-11-28 2012-04-26 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド ニューレグリン及び心臓幹細胞
CN102470161A (zh) * 2009-06-09 2012-05-23 上海泽生科技开发有限公司 神经调节蛋白用于治疗心力衰竭的有效剂量

Similar Documents

Publication Publication Date Title
JP2010539107A5 (https=)
Guibert et al. Organ preservation: current concepts and new strategies for the next decade
Salleo et al. Starch-to-sugar conversion in wood parenchyma of field-growing Laurus nobilis plants: a component of the signal pathway for embolism repair?
Bruinsma et al. Subzero organ preservation: the dawn of a new ice age?
CN103168836B (zh) 一种含功能性氨基酸的草莓防腐保鲜剂
WO2010096821A3 (en) Method for ice-free cryopreservation of tissue
CN101971798A (zh) 人脐带华通氏胶组织块冻存保护液
Kushnarenko et al. Cold acclimation improves regrowth of cryopreserved apple shoot tips
CN108094405B (zh) 细胞冻存组合物及其应用
WO2010049996A1 (ja) 哺乳動物の臓器の保存方法
RU2017140605A (ru) Способ консервации клеток, тканей или органов посредством гипотермии
Tsutsumi et al. Cardiac transplantation following a 24-h preservation using a perfusion apparatus
CN102422869A (zh) 一种河豚鱼的保鲜方法
Volk Application of functional genomics and proteomics to plant cryopreservation
ES2571340T3 (es) Métodos y composiciones para la criopreservación de órganos
WO2012058479A3 (en) Method of improving transplant function using soluble complement receptor type i (scr1)
Yemaneberhan et al. Beyond the icebox: modern strategies in organ preservation for transplantation
JP6027300B2 (ja) 細胞または臓器の保存液および保存方法
CN103262837B (zh) 一种家畜精液冷冻保护剂及其应用
CN104255711B (zh) 一种提高百合胚性愈伤组织保存效果的方法
Soares et al. Comparison between Perfadex and locally manufactured low-potassium dextran solution for pulmonary preservation in an ex vivo isolated lung perfusion model
JP2006306821A (ja) 細胞・組織の凍結障害防止液及び凍結保存法
CN103155913B (zh) 一种小麦幼胚的冷冻储藏方法
Schreinemachers et al. Machine perfusion preservation of the liver: a worthwhile clinical activity?
JP2010200749A5 (https=)